200 related articles for article (PubMed ID: 11943260)
21. A polymorphism in the P2X7 gene increases susceptibility to extrapulmonary tuberculosis.
Fernando SL; Saunders BM; Sluyter R; Skarratt KK; Goldberg H; Marks GB; Wiley JS; Britton WJ
Am J Respir Crit Care Med; 2007 Feb; 175(4):360-6. PubMed ID: 17095747
[TBL] [Abstract][Full Text] [Related]
22. CD39 activity correlates with stage and inhibits platelet reactivity in chronic lymphocytic leukemia.
Pulte D; Olson KE; Broekman MJ; Islam N; Ballard HS; Furman RR; Olson AE; Marcus AJ
J Transl Med; 2007 May; 5():23. PubMed ID: 17480228
[TBL] [Abstract][Full Text] [Related]
23. P2X7 gene polymorphisms do not appear to be a susceptibility gene locus in sporadic cases of systemic lupus erythematosus.
Forchap SL; Anandacoomarasamy A; Wicks J; Di Virgilio F; Baricordi OR; Rubini M; Trotta F; Wiley J; Manolios N
Tissue Antigens; 2008 Nov; 72(5):487-90. PubMed ID: 18937793
[TBL] [Abstract][Full Text] [Related]
24. Lack of association between the TNF-alpha promoter gene polymorphism and susceptibility to B-cell chronic lymphocytic leukaemia.
Bogunia-Kubik K; Mazur G; Urbanowicz I; Wróbel T; Kuliczkowski K; Woźniak M; Lange A
Int J Immunogenet; 2006 Feb; 33(1):21-4. PubMed ID: 16426238
[TBL] [Abstract][Full Text] [Related]
25. Monoclonal B-cell lymphocytosis in first-degree relatives of patients with sporadic (non-familial) chronic lymphocytic leukaemia.
Matos DM; Ismael SJ; Scrideli CA; de Oliveira FM; Rego EM; Falcão RP
Br J Haematol; 2009 Nov; 147(3):339-46. PubMed ID: 19709083
[TBL] [Abstract][Full Text] [Related]
26. Contribution of the P2X7 1513A/C loss-of-function polymorphism to extrapulmonary tuberculosis susceptibility in Tunisian populations.
Ben-Selma W; Ben-Kahla I; Boukadida J; Harizi H
FEMS Immunol Med Microbiol; 2011 Oct; 63(1):65-72. PubMed ID: 21635566
[TBL] [Abstract][Full Text] [Related]
27. Expression of P2X(7) purinoceptors on human lymphocytes and monocytes: evidence for nonfunctional P2X(7) receptors.
Gu BJ; Zhang WY; Bendall LJ; Chessell IP; Buell GN; Wiley JS
Am J Physiol Cell Physiol; 2000 Oct; 279(4):C1189-97. PubMed ID: 11003599
[TBL] [Abstract][Full Text] [Related]
28. R270C polymorphism leads to loss of function of the canine P2X7 receptor.
Spildrejorde M; Bartlett R; Stokes L; Jalilian I; Peranec M; Sluyter V; Curtis BL; Skarratt KK; Skora A; Bakhsh T; Seavers A; McArthur JD; Dowton M; Sluyter R
Physiol Genomics; 2014 Jul; 46(14):512-22. PubMed ID: 24824213
[TBL] [Abstract][Full Text] [Related]
29. Genetic polymorphisms in the P2X7 gene and its association with susceptibility to tuberculosis.
Singla N; Gupta D; Joshi A; Batra N; Singh J
Int J Tuberc Lung Dis; 2012 Feb; 16(2):224-9. PubMed ID: 22137490
[TBL] [Abstract][Full Text] [Related]
30. Evidence for distinct pathomechanisms in genetic subgroups of chronic lymphocytic leukemia revealed by quantitative expression analysis of cell cycle, activation, and apoptosis-associated genes.
Kienle DL; Korz C; Hosch B; Benner A; Mertens D; Habermann A; Kröber A; Jäger U; Lichter P; Döhner H; Stilgenbauer S
J Clin Oncol; 2005 Jun; 23(16):3780-92. PubMed ID: 15867199
[TBL] [Abstract][Full Text] [Related]
31. Intragenic Variations in BTLA Gene Influence mRNA Expression of BTLA Gene in Chronic Lymphocytic Leukemia Patients and Confer Susceptibility to Chronic Lymphocytic Leukemia.
Karabon L; Partyka A; Jasek M; Lech-Maranda E; Grzybowska-Izydorczyk O; Bojarska-Junak A; Pawlak-Adamska E; Tomkiewicz A; Robak T; Rolinski J; Frydecka I
Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):137-145. PubMed ID: 27933341
[TBL] [Abstract][Full Text] [Related]
32. A Glu-496 to Ala polymorphism leads to loss of function of the human P2X7 receptor.
Gu BJ; Zhang W; Worthington RA; Sluyter R; Dao-Ung P; Petrou S; Barden JA; Wiley JS
J Biol Chem; 2001 Apr; 276(14):11135-42. PubMed ID: 11150303
[TBL] [Abstract][Full Text] [Related]
33. Expression and function of the FAS antigen in B chronic lymphocytic leukemia and hairy cell leukemia.
Panayiotidis P; Ganeshaguru K; Foroni L; Hoffbrand AV
Leukemia; 1995 Jul; 9(7):1227-32. PubMed ID: 7543175
[TBL] [Abstract][Full Text] [Related]
34. Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo.
Di Ianni M; Moretti L; Terenzi A; Bazzucchi F; Del Papa B; Bazzucchi M; Ciurnelli R; Lucchesi A; Sportoletti P; Rosati E; Marconi PF; Falzetti F; Tabilio A
Cytotherapy; 2009; 11(1):86-96. PubMed ID: 19153855
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-1B (IL1B) and interleukin-6 (IL6) gene polymorphisms are associated with risk of chronic lymphocytic leukaemia.
Ennas MG; Moore PS; Zucca M; Angelucci E; Cabras MG; Melis M; Gabbas A; Serpe R; Madeddu C; Scarpa A; Cocco P
Hematol Oncol; 2008 Jun; 26(2):98-103. PubMed ID: 18271063
[TBL] [Abstract][Full Text] [Related]
36. Differential expression of the Bcl-2 and Bax isoforms in CD19 positive B-lymphocytes isolated from patients diagnosed with chronic lymphocytic leukaemia.
Ghassemifar R; Forster L; Finlayson J; Calogero T; Augustson B; Joske D; Cull G
Pathology; 2012 Dec; 44(7):632-7. PubMed ID: 23172082
[TBL] [Abstract][Full Text] [Related]
37. CD40 triggering enhances fludarabine-induced apoptosis of chronic lymphocytic leukemia B-cells through autocrine release of tumor necrosis factor-alpha and interferon-gama and tumor necrosis factor receptor-I-II upregulation.
de Totero D; Tazzari PL; Capaia M; Montera MP; Clavio M; Balleari E; Foa R; Gobbi M
Haematologica; 2003 Feb; 88(2):148-58. PubMed ID: 12604404
[TBL] [Abstract][Full Text] [Related]
38. P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia.
Adinolfi E; Melchiorri L; Falzoni S; Chiozzi P; Morelli A; Tieghi A; Cuneo A; Castoldi G; Di Virgilio F; Baricordi OR
Blood; 2002 Jan; 99(2):706-8. PubMed ID: 11781259
[TBL] [Abstract][Full Text] [Related]
39. Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status.
Hüttmann A; Klein-Hitpass L; Thomale J; Deenen R; Carpinteiro A; Nückel H; Ebeling P; Führer A; Edelmann J; Sellmann L; Dührsen U; Dürig J
Leukemia; 2006 Oct; 20(10):1774-82. PubMed ID: 16932341
[TBL] [Abstract][Full Text] [Related]
40. Molecular allelokaryotyping of early-stage, untreated chronic lymphocytic leukemia.
Lehmann S; Ogawa S; Raynaud SD; Sanada M; Nannya Y; Ticchioni M; Bastard C; Kawamata N; Koeffler HP
Cancer; 2008 Mar; 112(6):1296-305. PubMed ID: 18246537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]